értekezés - Semmelweis Egyetem Doktori Iskola
értekezés - Semmelweis Egyetem Doktori Iskola értekezés - Semmelweis Egyetem Doktori Iskola
43. Cohen D, Koh GY, Nikonova LN, Porter JG, Maack T. Molecular determinants of the clearance function of type C receptors of natriuretic peptides. J Biol Chem 1996; 271: 9863-9. 44. Sonnenberg JL, Sakane Y, Jeng AY, Koehn JA, Ansell JA, Wennogle LP, Ghai RD. Identification of protease 3.4.24.11 as the major atrial natriuretic factor degrading enzyme in the rat kidney. Peptides 1988; 9: 173-80. 45. Akashi YJ, Springer J, Lainscak M, Anker SD. Atrial natriuretic peptide and related peptides. Clin Chem Lab Med 2007; 45: 1259-67. 46. Okolicany J, McEnroe GA, Koh GY, Lewicki JA, Maack T. Clearance receptor and neutral endopeptidase-mediated metabolism of atrial natriuretic factor. Am J Physiol 1992; 263: F546-53. 47. Boerrigter G, Burnett JC Jr. Recent advances in natriuretic peptides in congestive heart failure. Expert Opin Investig Drugs 2004; 13: 643-52. 48. Schulz S, Singh S, Bellet RA, Singh G, Tubb DJ, Chin H, Garbers DL. The primary structure of a plasma membrane guanylate cyclase demonstrates diversity within this new receptor family. Cell 1989; 58: 1155-62. 49. Fenrick R, Babinski K, McNicoll N, Therrien M, Drouin J, De Léan A. Cloning and functional expression of the bovine natriuretic peptide receptor-B (natriuretic factor R1c subtype. Mol Cell Biochem 1994; 137: 173-82. 50. Suga S, Nakao K, Hosoda K, Mukoyama M, Ogawa Y, Shirakami G, Arai H, Saito Y, Kambayashi Y, Inouye K, et al. Receptor selectivity of natriuretic peptide family, atrial natriuretic peptide, brain natriuretic peptide, and C-type natriuretic peptide. Endocrinology 1992; 130: 229-39. 51. Smith MW, Espiner EA, Yandle TG, Charles CJ, Richards AM. Delayed metabolism of human brain natriuretic peptide reflects resistance to neutral endopeptidase. J Endocrinol 2000; 167: 239-46. 52. Pemberton CJ, Johnson ML, Yandle TG, Espiner EA. Deconvolution analysis of cardiac natriuretic peptides during acute volume overload. Hypertension 2000; 36: 355-9. 53. Davis GK, Bamforth F, Sarpal A, Dicke F, Rabi Y, Lyon ME. B-type natriuretic peptide in pediatrics. Clin Biochem 2006; 39: 600-5. 92
54. Lang RE, Thölken H, Ganten D, Luft FC, Ruskoaho H, Unger T. Atrial natriuretic factor – a circulating hormone stimulated by volume loading. Nature 1985; 314: 264-6. 55. Ruskoaho H, Thölken H, Lang RE. Increase in atrial pressure releases atrial natriuretic peptide from isolated perfused rat hearts. Pflugers Arch 1986; 407: 170-4. 56. Edwards BS, Zimmerman RS, Schwab TR, Heublein DM, Burnett JC Jr. Atrial stretch, not pressure, is the principal determinant controlling the acute release of atrial natriuretic factor. Circ Res 1988; 62: 191-5. 57. Kinnunen P, Vuolteenaho O, Uusimaa P, Ruskoaho H. Passive mechanical stretch releases atrial natriuretic peptide from rat ventricular myocardium. Circ Res 1992; 70: 1244-53. 58. Weil J, Lang RE, Suttmann H, Rampf U, Bidlingmaier F, Gerzer R. Concomitant increase in plasma atrial natriuretic peptide and cyclic GMP during volume loading. Klin Wochenschr 1985; 63: 1265-8. 59. Sagnella GA, Markandu ND, Shore AC, MacGregor GA. Effects of changes in dietary sodium intake and saline infusion on immunoreactive atrial natriuretic peptide in human plasma. Lancet 1985; 2: 1208-11. 60. Tulassay T, Ruskoaho H, Tóth M, Rascher W. Atrial natriuretic peptide in volume expansion-induced natriuresis in man. Clin Exp Hypertens A 1988; 10: 363-80. 61. Shenker Y, Sider RS, Ostafin EA, Grekin RJ. Plasma levels of immunoreactive atrial natriuretic factor in healthy subjects and in patients with edema. J Clin Invest 1985; 76: 1684-7. 62. Crozier IG, Ikram H, Nicholls MG, Espiner EA, Yandle TG. Atrial natriuretic peptide in spontaneous tachycardias. Br Heart J 1987; 58: 96-100. 63. Nishimura K, Soneda J, Nomoto S, Matsumoto M, Fujiwara Y, Konishi Y, Okamoto Y, Ban T, Sugawara A, Nakao K, Imura H. Atrial natriuretic polypeptide increases during atrial pacing. Jpn Circ J 1986; 50: 727-732. 64. Ikäheimo MJ, Ruskoaho HJ, Airaksinen KE, Huikuri HV, Korhonen UR, Leppäluoto PJ, Tuominen MO, Takkunen JT. Plasma levels of atrial natriuretic 93
- Page 41 and 42: meghatározása a termális (indik
- Page 43 and 44: állapítottuk meg. A karbamid nitr
- Page 45 and 46: 4. Eredmények 4.1. A vizsgálatokb
- Page 47 and 48: 2. táblázat A vizsgált betegpopu
- Page 49 and 50: 4.4. A nátriuretikus peptidek szin
- Page 51 and 52: Az alcsoport vizsgálatban (II. pop
- Page 53 and 54: ln NT-proXNP (pmol/l) 10,0 8,0 6,0
- Page 55 and 56: 4.6. A hemodinamikai paraméterek j
- Page 57 and 58: A műtét után egy nappal az SVI
- Page 59 and 60: 4.6.5. A hemodinamikai paraméterek
- Page 61 and 62: delta CI (l/min/m2) 8.0 4.0 0.0 -4.
- Page 63 and 64: 4.7.2. A klinikai paraméterek öss
- Page 65 and 66: 4.9. A nátriuretikus peptidek diag
- Page 67 and 68: 5. Megbeszélés Egy 10 év adatait
- Page 69 and 70: verőtérfogat műtét utáni vált
- Page 71 and 72: lélegeztetve. A felnőttekben elfo
- Page 73 and 74: mediátorok felszabadulását okozz
- Page 75 and 76: mind az NT-proBNP molekulából tar
- Page 77 and 78: 5.4. A nátriuretikus peptidek és
- Page 79 and 80: magasabb NT-proANP szintek és a na
- Page 81 and 82: emelkedése megelőzi a vesefunkci
- Page 83 and 84: kockázatokkal járhat a betegekre
- Page 85 and 86: 5. A szívindex referencia értéke
- Page 87 and 88: Summary Natriuretic peptide levels
- Page 89 and 90: 12. Sudoh T, Minamino N, Kangawa K,
- Page 91: 33. Murakami Y, Shimada T, Inoue S,
- Page 95 and 96: 75. Fukuda Y, Hirata Y, Taketani S,
- Page 97 and 98: 95. Yoshimoto T, Naruse M, Tanabe A
- Page 99 and 100: 116. Tei M, Horie M, Makita T, Suzu
- Page 101 and 102: esponses to brain natriuretic pepti
- Page 103 and 104: paracrine factor in cultured cardia
- Page 105 and 106: 174. Matsuoka S, Kurahashi Y, Tomim
- Page 107 and 108: 191. Lan YT, Chang RK, Alejos JC, B
- Page 109 and 110: 213. Egan JR, Festa M, Cole AD, Nun
- Page 111 and 112: 234. Lehot JJ, Villard J, Piriz H,
- Page 113 and 114: 4. Székely A, Sápi E, Breuer T, K
43. Cohen D, Koh GY, Nikonova LN, Porter JG, Maack T. Molecular determinants<br />
of the clearance function of type C receptors of natriuretic peptides. J Biol Chem<br />
1996; 271: 9863-9.<br />
44. Sonnenberg JL, Sakane Y, Jeng AY, Koehn JA, Ansell JA, Wennogle LP, Ghai<br />
RD. Identification of protease 3.4.24.11 as the major atrial natriuretic factor<br />
degrading enzyme in the rat kidney. Peptides 1988; 9: 173-80.<br />
45. Akashi YJ, Springer J, Lainscak M, Anker SD. Atrial natriuretic peptide and<br />
related peptides. Clin Chem Lab Med 2007; 45: 1259-67.<br />
46. Okolicany J, McEnroe GA, Koh GY, Lewicki JA, Maack T. Clearance receptor<br />
and neutral endopeptidase-mediated metabolism of atrial natriuretic factor. Am J<br />
Physiol 1992; 263: F546-53.<br />
47. Boerrigter G, Burnett JC Jr. Recent advances in natriuretic peptides in<br />
congestive heart failure. Expert Opin Investig Drugs 2004; 13: 643-52.<br />
48. Schulz S, Singh S, Bellet RA, Singh G, Tubb DJ, Chin H, Garbers DL. The<br />
primary structure of a plasma membrane guanylate cyclase demonstrates<br />
diversity within this new receptor family. Cell 1989; 58: 1155-62.<br />
49. Fenrick R, Babinski K, McNicoll N, Therrien M, Drouin J, De Léan A. Cloning<br />
and functional expression of the bovine natriuretic peptide receptor-B<br />
(natriuretic factor R1c subtype. Mol Cell Biochem 1994; 137: 173-82.<br />
50. Suga S, Nakao K, Hosoda K, Mukoyama M, Ogawa Y, Shirakami G, Arai H,<br />
Saito Y, Kambayashi Y, Inouye K, et al. Receptor selectivity of natriuretic<br />
peptide family, atrial natriuretic peptide, brain natriuretic peptide, and C-type<br />
natriuretic peptide. Endocrinology 1992; 130: 229-39.<br />
51. Smith MW, Espiner EA, Yandle TG, Charles CJ, Richards AM. Delayed<br />
metabolism of human brain natriuretic peptide reflects resistance to neutral<br />
endopeptidase. J Endocrinol 2000; 167: 239-46.<br />
52. Pemberton CJ, Johnson ML, Yandle TG, Espiner EA. Deconvolution analysis of<br />
cardiac natriuretic peptides during acute volume overload. Hypertension 2000;<br />
36: 355-9.<br />
53. Davis GK, Bamforth F, Sarpal A, Dicke F, Rabi Y, Lyon ME. B-type natriuretic<br />
peptide in pediatrics. Clin Biochem 2006; 39: 600-5.<br />
92
Change language